|
- Purdue Pharma
Purdue Pharma and its subsidiaries are physician-founded and physician-led companies that develop, manufacture and market medications and consumer health products to meet the evolving needs of healthcare professionals, patients, consumers and caregivers
- Purdue Pharma L. P. Files New Plan of Reorganization Providing for More . . .
Purdue Pharma L P Files New Plan of Reorganization Providing for More Than $7 4 Billion in Creditor Distributions; New Study Explores Nalmefene and Naloxone for Reversal of Respiratory Depression Induced by Fentanyl in a Clinical Opioid Induced Respiratory Depression Model
- Restructure - Purdue Pharma
Purdue Pharma Bankruptcy In March 2025, Purdue Pharma L P filed a new Chapter 11 Plan of Reorganization and related disclosure statement with the United States Bankruptcy Court for the Southern District of New York Read the press release here
- Healthcare Professionals - Purdue Pharma
Purdue Pharma develops and provides prescription medicines that meet the evolving needs of healthcare professionals, patients, and caregivers For decades, we have developed medications that manage pain
- Locations | Purdue Pharma
Purdue Pharmaceuticals L P 4701 International Blvd W Wilson, NC 27893 Main Phone: 203‑588‑8000 Main Fax: 203‑588‑8850 Driving Directions
- Products - Purdue Pharma
Purdue and its subsidiaries are pioneers in medical science with a patient-first approach in developing prescription and non-prescription medications We focus on balancing innovative science with clinically effective, compassionate care
- News Media - Purdue Pharma
STAMFORD, Conn , August 7, 2024 – Purdue Pharma L P (“Purdue”) announced today that the U S Food and Drug Administration (FDA) approved the Company’s new drug application for the Zurnai™ (nalmefene injection) Auto-Injector Zurnai (zur nye) is a single-dose…
- Medicines From Purdue - Purdue Pharma
Purdue is a pioneer in healthcare, with a patient-first approach in developing medicines We combine medical science with compassionate care in every phase of drug research and manufacturing
|
|
|